TrialInternational journal of chronic obstructive pulmonary disease

A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy.

Gary T Ferguson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.